Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom
Abstract
Authors
E. Zimovetz S.M. Beard P. Hodgkins M. Bischof J.A. Mauskopf J. Setyawan